Jade Biosciences Stock Price, News & Analysis
JBIO
NASDAQ
Company Description
Welcome to the overview page for Jade Biosciences (JBIO), where you can find comprehensive stock information and company updates.
Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.
Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.
Stock Performance
$8.86
0.00%
0.00
Last updated: October 5, 2025 at 15:59
-30.67 %
Performance 1 year
$271.8M
32.6M
Latest News
SEC Filings
Financial Highlights
$590
Net Income (TTM)
$0.86
$38,916
Operating Cash Flow
10.31
$27,778
—
Revenue (TTM)
Upcoming Events
JAN
01
January 1, 2026 - June 30, 2026
Clinical
Interim trial data
Interim human trial data release for JADE101
JAN
01
January 1, 2026 - June 30, 2026
Clinical
JADE101 interim data
Interim clinical data expected for JADE101 Phase 1 trials
JAN
01
January 1, 2026 - June 30, 2026
Clinical
Interim data report
Expected interim data report for Phase 1 JADE101 clinical trial
JAN
01
January 1, 2026 - April 30, 2026
Clinical
JADE201 clinical entry
Planned clinical entry for JADE201 targeting systemic autoimmune diseases in H1 2026
Short Interest History
Last 12 Months
Loading short interest data...
Days to Cover History
Last 12 Months
Loading days to cover data...
Frequently Asked Questions
What is the current stock price of Jade Biosciences (JBIO)?
The current stock price of Jade Biosciences (JBIO) is $8.86 as of October 3, 2025.
What is the market cap of Jade Biosciences (JBIO)?
The market cap of Jade Biosciences (JBIO) is approximately 271.8M. Learn more about what market capitalization means .
What is the net income of Jade Biosciences (JBIO)?
The trailing twelve months (TTM) net income of Jade Biosciences (JBIO) is $590.
What is the earnings per share (EPS) of Jade Biosciences (JBIO)?
The diluted earnings per share (EPS) of Jade Biosciences (JBIO) is $0.86 on a trailing twelve months (TTM) basis. Learn more about EPS .
What is the operating cash flow of Jade Biosciences (JBIO)?
The operating cash flow of Jade Biosciences (JBIO) is $38,916. Learn about cash flow.
What is the current ratio of Jade Biosciences (JBIO)?
The current ratio of Jade Biosciences (JBIO) is 10.31, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.
What is the operating income of Jade Biosciences (JBIO)?
The operating income of Jade Biosciences (JBIO) is $27,778. Learn about operating income.